Functional drug response profiling predicts clinical outcomes and shows utility for treatment stratification in AML

Aleksej Drino(Medical University of Vienna), Nikolaus Krall(Austrian Centre of Industrial Biotechnology (Austria)), Ulrich Keller(Humboldt-Universität zu Berlin), Daniel Udvary(BioScientia (Poland)), Armin Zebisch(Medical University of Graz), Artur Speiser(Max Planck Society), Jeffrey A. Boatman(University of Minnesota), P Kovács(Austrian Centre of Industrial Biotechnology (Austria)), Joost Van Ham(BioScientia (Poland)), Heikki Kuusanmäki(University of Helsinki), Mika Kontro(Finnish Cancer Registry), Bekir Ergüner(Austrian Centre of Industrial Biotechnology (Austria)), Tzi‐Yang Lin(Research Institute of Molecular Pathology), Heinz Sill(Medical University of Graz), Stephan Bohl(Humboldt-Universität zu Berlin), Giuseppe Fiume(Austrian Centre of Industrial Biotechnology (Austria)), Rebecca Kirkley(BioScientia (Poland)), Claudia Baumgärtler(Austrian Centre of Industrial Biotechnology (Austria)), Sayantanee Dutta(Medical University of Graz), Sarah Himbert-Baudis(BioScientia (Poland)), Tom Kruitwagen(BioScientia (Poland))
Blood
November 3, 2025
Cited by 0


Related Papers